Chemoinformaics analysis of 3-O-methyl-isosecotanapartholide
| Molecular Weight | 292.331 | nRot | 5 |
| Heavy Atom Molecular Weight | 272.171 | nRig | 14 |
| Exact Molecular Weight | 292.131 | nRing | 2 |
| Solubility: LogS | -2.286 | nHRing | 1 |
| Solubility: LogP | 0.435 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 44.0659 |
| nHD | 0 | BPOL | 26.1401 |
| QED | 0.57 |
| Synth | 4.276 |
| Natural Product Likeliness | 2.498 |
| NR-PPAR-gamma | 0.965 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.046 |
| Pgp-sub | 0.001 |
| HIA | 0.174 |
| CACO-2 | -4.619 |
| MDCK | 0.0000184 |
| BBB | 0.887 |
| PPB | 0.698699 |
| VDSS | 0.483 |
| FU | 0.300816 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.257 |
| CYP2c19-inh | 0.123 |
| CYP2c19-sub | 0.815 |
| CYP2c9-inh | 0.084 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.348 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.352 |
| CL | 7.994 |
| T12 | 0.421 |
| hERG | 0.01 |
| Ames | 0.081 |
| ROA | 0.477 |
| SkinSen | 0.552 |
| Carcinogencity | 0.813 |
| EI | 0.109 |
| Respiratory | 0.919 |
| NR-Aromatase | 0.839 |
| Antiviral | Yes |
| Prediction | 0.810793 |